Search alternatives:
significant proportion » significant reduction (Expand Search)
proportion decrease » proportional decrease (Expand Search), proportion increases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
significant proportion » significant reduction (Expand Search)
proportion decrease » proportional decrease (Expand Search), proportion increases (Expand Search)
point decrease » point increase (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
-
21
-
22
-
23
-
24
-
25
-
26
-
27
Mechanical performance parameters of similar materials with different proportions.
Published 2024Subjects: -
28
-
29
Cox proportional hazard ratios.
Published 2025“…Current locoregional therapies to treat breast cancer liver metastases are non-specific and have not produced significant increases in survival. …”
-
30
-
31
Downregulation of DOM decreases the abundance of PER and TIM.
Published 2019“…Error bars represent ± SEM; n.s., non significant,*<i>P</i> < 0.05,**p < 0.01, ***p < 0.001, one-way ANOVA. …”
-
32
-
33
-
34
-
35
DataSheet_1_Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cance...
Published 2023“…Patients with decreased MLR had a significantly higher ORR in the univariate (P<0.001) and multivariate (P<0.001) Cox proportional hazards models. …”
-
36
-
37
-
38
AMPs are increased in lesional HS, but DCD and other sweat-gland associated proteins are decreased.
Published 2019“…Genes represented in orange were unchanged (FC < 2, p-adj < 0.05) in HS lesional vs. HS non-lesional skin. Non-adjusted p-values were used for generation of the volcano plot to minimize points with tied y-values but significance level was set using the corresponding non-adjusted p-values. …”
-
39
Bar graph showing proportion of NADCs.
Published 2025“…The risk of ADCs increased from stage 2 (OR: 0.46, p-value: 0.03; 95% CI: 0.23–0.91) to stage 3 (OR: 1.13; p-value: 0.66; 95% CI: 0.65–1.97) but this was not statistically significant. The risk of ADCs decreased with increasing ART duration (<i>P</i> value < 0.05).…”
-
40